Jennifer Dykhouse
Medical · Grand Rapids, MINPI 1881769321
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 438 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 438 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$968
- Johnson & Johnson$617
- E.r. Squibb & Sons, L.L.C.$605
- Novo Nordisk$474
- Merck$472
- Amgen$447
- plus $4K from 35 others
What the payments were for
- Food & beverage$7,31796%
- Education$2744%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Confirm Rx$149
How this compares
$7,590 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 231 | $281,706 |
| EntrestoSacubitril/Valsartan | 83 | $96,158 |
| XareltoRivaroxaban | 56 | $51,681 |
| Repatha SureclickEvolocumab | 35 | $46,788 |
| JardianceEmpagliflozin | 40 | $43,195 |
| FarxigaDapagliflozin Propanediol | 26 | $30,337 |
| BrilintaTicagrelor | 34 | $26,165 |
| Metoprolol Succinate | 338 | $8,802 |
| Atorvastatin Calcium | 297 | $5,655 |
| Rosuvastatin Calcium | 208 | $5,236 |
| Ezetimibe | 128 | $5,013 |
| Ranolazine ErRanolazine | 46 | $3,850 |
| Losartan Potassium | 165 | $2,995 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 126 | $2,676 |
| ClopidogrelClopidogrel Bisulfate | 146 | $2,455 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $273 | $281,706231 claims |
| NovartisEntresto | $968 | $96,15883 claims |
| AstraZenecaFarxiga, Brilinta | $420 | $56,50260 claims |
| Johnson & JohnsonXarelto | $617 | $51,68156 claims |
| Boehringer IngelheimJardiance | $339 | $43,19540 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 755 medical providers in Michigan.
Other medical in Grand Rapids
- Meredith KentGrand Rapids$192K
- David BarneyGrand Rapids$21K
- Nisha McKenzieGrand Rapids$19K
- Brenda WhartonGrand Rapids$11K
- Andra TalaskaGrand Rapids$11K
- Evan GerondaleGrand Rapids$7K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.